Chetan Raina, CFA
Chief Executive Officer
15+ years of finance, investing and operations experience. Formerly Managing Director at Good Hill Partners LP, a hedge fund in Westport, CT, USA.
Carl Laflamme, PhD
Chief Science Officer
A molecular biologist. Authored key eLife paper outlining antibody characterization procedure.
Peter S. McPherson, PhD
Distinguished James McGill Professor at The Montreal Neurological Institute. Lead Academic on key technology paper.
Thomas M. Durcan, PhD
Assistant Professor at The Montreal Neurological Institute. Lead Academic on key technology paper.
Riham Ayoubi, PhD
Expert biochemist. Western blot and immunoprecipitation expert trained by Drs. Annie Anger (Université de Montréal) and Peter McPherson (McGill).
Walaa Alshafie, PhD
Imaging specialist. Trained by Drs. Thomas Stroh and Peter McPherson at the Montreal Neurological Institute (McGill). Walaa is optimizing the automation of the antibody screening procedure by immunofluorescence.
Worked for 15 years in the laboratory of Peter McPherson. Maryam has been involved in training dozens of students and postdoctoral fellows for various antibody-based experiments.
Aled Edwards, PhD
CEO of the Structural Genomics Consortium.